Village-based program to manage chronic heart conditions in Qujiang older adults
Village-Based Management of Chronic Cardiovascular Disease in Qu Jiang Elderly Population Registry: The BOUQUET Cohort Study
This project will try a village-based program combining medicines, lifestyle support, education, and 7-day ECG monitoring for people aged 60+ in Qujiang with chronic heart conditions such as atrial fibrillation, high blood pressure, coronary artery disease, or heart failure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30000 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT07149688 on ClinicalTrials.gov |
What this trial studies
The BOUQUET cohort is a prospective, village-based observational study enrolling about 30,000 residents aged 60 and older in Qujiang District with chronic cardiovascular diseases. Participants are offered a comprehensive management program including standardized pharmacologic treatment, lifestyle modification counseling, health education, structured long-term follow-up, and enhanced monitoring with 7-day ECG recordings. Data on clinical events, medication adherence, functional status, and quality of life will be collected and linked to routine care records. Outcomes will be followed for up to 10 years to observe rates of major cardiovascular events, hospitalizations, and mortality in a real-world community setting.
Who should consider this trial
Good fit: Ideal candidates are Qujiang District residents aged 60 or older with a diagnosis of chronic cardiovascular disease (hypertension, coronary artery disease, atrial fibrillation, or heart failure) who can give informed consent and participate in long-term follow-up.
Not a fit: Patients with severe cognitive impairment, a non-cardiovascular life expectancy under one year, or those unwilling or unable to participate in regular follow-up are unlikely to gain benefit from this program.
Why it matters
Potential benefit: If successful, the program could lower heart-related hospitalizations and deaths and improve quality of life for older adults in rural communities.
How similar studies have performed: Integrated chronic disease management programs have previously improved risk factor control and reduced hospitalizations in older adults, though very large community-based cohorts with extended ECG monitoring are relatively uncommon.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria Age ≥60 years Resident of Qujiang District Diagnosed with chronic CVD (hypertension, coronary artery disease, heart failure, atrial fibrillation, or others) Able and willing to provide informed consent Exclusion Criteria Severe cognitive impairment or inability to provide consent Life expectancy \<1 year due to non-cardiovascular disease Participation refusal
Where this trial is running
Beijing, Beijing Municipality
- Beijing Anzhen Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Le Zhou, MD
- Email: 13840293506@163.com
- Phone: +8613840293506
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.